Management of desmoid tumours: A large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments.

United European Gastroenterol J 2017 Aug 28;5(5):735-741. Epub 2016 Oct 28.

Gastroenterology Department, Edouard Herriot Hospital, Lyon, France.

Background: Desmoid tumours represent a major complication of familial adenomatous polyposis. Our aims were to study the factors associated with the development of desmoid tumours in familial adenomatous polyposis patients, and to describe presentation and management of desmoid tumours.

Methods And Patients: We reviewed all patients with familial adenomatous polyposis followed at our institution between 1965-2013, with either identified adenomatous polyposis coli gene mutation, or a personal and family history suggesting adenomatous polyposis coli-related polyposis. Response to treatment of desmoid tumours was assessed by Response Evaluation Criteria In Solid Tumor (RECIST) criteria.

Results: A total of 180 patients with familial adenomatous polyposis were included with a median follow-up of 19 years since diagnosis. Thirty-one (17%) patients developed 58 desmoid tumours, a median (range) 4.7 (0.8-41.6) years after their diagnosis of familial adenomatous polyposis. The only factor significantly associated with occurrence of desmoid tumours was the type of surgery: 12 (12%) desmoid tumours in 104 patients treated by colectomy, versus 19 (25%) desmoid tumours in 76 patients treated by proctocolectomy,  = 0.027. The localisation of desmoid tumours was: mesenteric ( = 25), abdominal wall ( = 30) or extra-abdominal ( = 3). Nineteen patients underwent 36 surgical procedures for desmoid tumours. Recurrence occurred in 26 (72%) cases and the recurrence-free survival was 2.6 (95% confidence interval (CI), 0.2-5.9) years. Thirteen patients received 27 medical treatments over a median 14 months. Objective response was observed in four (15%) patients and the median progression-free survival was nine (95% CI, 1.1-16.9) months.

Conclusion: If confirmed, colectomy (versus proctocolectomy) should be performed in adenomatous polyposis coli-related familial adenomatous polyposis patients to avoid desmoid tumours. We show that there is a high prevalence of post-surgical recurrence and the low efficacy of available medical treatments for desmoid tumours.

Download full-text PDF

Source Listing
August 2017
5 Reads

Publication Analysis

Top Keywords

desmoid tumours
adenomatous polyposis
familial adenomatous
medical treatments
years diagnosis
polyposis coli-related
low efficacy
survival 95%
efficacy medical
patients treated
polyposis patients
management desmoid
patients familial
colectomy versus

Similar Publications

Small bowel obstruction in patients with familial adenomatous polyposis related desmoid disease.

X Xhaja J Church

Colorectal Dis 2013 Dec;15(12):1489-92

Department of Colorectal Surgery, Sanford R. Weiss Center for Hereditary Colorectal Neoplasia, Digestive Diseases Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Aim: Intra-abdominal desmoid disease is one of the most common extra-intestinal manifestations of familial adenomatous polyposis. Small bowel obstruction occurs frequently in affected patients and is notoriously difficult to treat. The aim of this study was to review the management and outcome of desmoid-related small bowel obstruction. Read More

View Article
December 2013

Desmoid tumor in patients with familial adenomatous polyposis.

Arq Gastroenterol 2010 Oct-Dec;47(4):373-8

UNICAMP, Brazil.

Context: Desmoid tumors constitute one of the most important extraintestinal manifestations of familial adenomatous polyposis. The development of desmoids is responsible for increasing morbidity and mortality rates in cases of familial adenomatous polyposis.

Objectives: To evaluate the occurrence of desmoid tumors in familial adenomatous polyposis cases following prophylactic colectomy and to present patient outcome. Read More

View Article
August 2011

Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.

Br J Cancer 2011 Jan 9;104(1):37-42. Epub 2010 Nov 9.

The Netherlands Foundation for the Detection of Hereditary Tumours, Rijnsburgerweg 10, Poortgebouw Zuid, 2333 AA Leiden, The Netherlands.

Background: The optimal treatment of desmoid tumours is controversial. We evaluated desmoid management in Dutch familial adenomatous polyposis (FAP) patients.

Methods: Seventy-eight FAP patients with desmoids were identified from the Dutch Polyposis Registry. Read More

View Article
January 2011

Urological sequelae of desmoids associated with familial adenomatous polyposis.

Fam Cancer 2018 Feb 27. Epub 2018 Feb 27.

Department of Urology, Northwick Park Hospital, Harrow, UK.

The aim of this retrospective cohort study was to review urological complication rates arising from familial adenomatous polyposis associated desmoid tumours and their management. All patients over a 35-year period were identified from a prospectively maintained polyposis registry database and had an intra-abdominal desmoid tumour. Those without ureteric complications (n = 118, group A) were compared to those that developed ureteric obstruction (n = 40, group B) for demographics, treatment interventions and survival outcomes. Read More

View Article
February 2018